LEADER 01570oam  2200457 a 450 
001 9910691935703321
005 20031201072731.0
035   $a(CKB)5470000002350059
035   $a(OCoLC)52390164
035 9 $aocm52390164
035   $a(OCoLC)995470000002350059
035   $a(EXLCZ)995470000002350059
100   $a20030609d2003      ua             0
101 0 $aeng
135   $aurmn||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aTechnology transfer$b[electronic resource] $eNIH-private sector partnership in the development of Taxol : report to the Honorable Ron Wyden, U.S. Senate
210  1$a[Washington, D.C.] :$cU.S. General Accounting Office,$d[2003]
300   $aTitle from title screen (viewed on June 9, 2003).
300   $a"June 2003."
300   $aPaper version available from: General Accounting Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
300   $a"GAO-03-829."
320   $aIncludes bibliographical references.
517   $aTechnology transfer 
606   $aPaclitaxel
606   $aCancer$xTreatment$xResearch
606   $aTechnology transfer
606   $aPharmaceutical industry$xTechnological innovations
615  0$aPaclitaxel.
615  0$aCancer$xTreatment$xResearch.
615  0$aTechnology transfer.
615  0$aPharmaceutical industry$xTechnological innovations.
801  0$bCFI
801  1$bCFI
801  2$bGPO
906   $aBOOK
912   $a9910691935703321
996   $aTechnology Transfer$9455360
997   $aUNINA